Bruker Preps for US Launch of MALDI Biotyper with Collaborations, Gains Distributor, Regulatory Nod in EU | GenomeWeb

As it prepares to bring its MALDI Biotyper to the US market, Bruker Daltonics this week announced collaborations with various partners in the US for the clinical validation of the instrument's workflow for microorganism identification.

Separately, the firm announced this week that the workflow received the IVD-CE mark in Europe and said last week that it had reached an exclusive distribution agreement for the Biotyper with Francisco Soria Melguizo in Spain.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.